| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药流通(元) | 341,406,644.15 | 526,240,019.75 | 286,122,615.24 | 208,535,547.48 |
| 医药制造(元) | 1,253,843,588.89 | 2,042,692,695.42 | 1,136,958,433.68 | 1,728,707,551.77 |
| 营业成本(元) | ||||
| 医药流通(元) | 289,902,042.43 | 441,772,373.07 | 245,412,630.12 | 165,084,512.46 |
| 医药制造(元) | 300,454,225.42 | 561,026,175.53 | 287,233,297.00 | 445,235,218.43 |
| 毛利(元) | ||||
| 医药流通(元) | 51,504,601.72 | 84,467,646.68 | 40,709,985.12 | 43,451,035.02 |
| 医药制造(元) | 953,389,363.47 | 1,481,666,519.89 | 849,725,136.68 | 1,283,472,333.34 |
| 毛利率(%) | ||||
| 医药流通(%) | 15.09 | 16.05 | 14.23 | 20.84 |
| 医药制造(%) | 76.04 | 72.53 | 74.74 | 74.24 |
| 收入构成(%) | ||||
| 医药流通(%) | 21.40 | 20.48 | 20.11 | 10.76 |
| 医药制造(%) | 78.60 | 79.52 | 79.89 | 89.24 |
| 毛利构成(%) | ||||
| 医药流通(%) | 5.13 | 5.39 | 4.57 | 3.27 |
| 医药制造(%) | 94.87 | 94.61 | 95.43 | 96.73 |